SureTrader Advertisement SureTrader
Home > Boards > Free Zone > Health and Sciences >

Biotech Values

RSS Feed
      Hide Sticky   Hide Intro
Moderator: DewDiligence Assistants: Biowatch
Search This Board:
Last Post: 4/30/2016 2:53:30 PM - Followers: 1292 - Board type: Free - Posts Today: 2

Biotech Values is a forum for discussing 
all facets of biotech investing with an emphasis
on fundamental analysis and avoiding scams.
We generally do not discuss microcap stocks.

Calendars and Compilations
Webcasts
Recent Biotech Buyouts
Buyouts of Biotech Partners
Announced FoB Collaborations

Common Biotech-Newbie Mistakes
Biotech Holdings of Selected Institutional Investors
US Patent Expirations for Big-Selling Biologics
Biotech and Miscellaneous Acronyms

Top Twitter Feeds for Biotech Info
iHub's Greatest Hits (thru 5/09)

PostSubject
#201067  Sticky Note Dew, yes I saw the drop in IMGN. vinmantoo 04/30/16 02:53:30 PM
#201064  Sticky Note Gilead Judge Re-Opens Case Amid Claim Merck Scientist jbog 04/29/16 09:49:37 PM
#201061  Sticky Note The U.S. Food and Drug Administration today approved WID 04/29/16 06:07:16 PM
#201051  Sticky Note ALR acknowledges that ABT tried to walk away DewDiligence 04/29/16 11:31:57 AM
#201043  Sticky Note OCRX: Ocera Therapeutics Reports First Quarter 2016 Financial ghmm 04/29/16 09:47:07 AM
#201042  Sticky Note MDVN rejects SNY’s buyout offer (again): DewDiligence 04/29/16 09:38:24 AM
#201067   Dew, yes I saw the drop in IMGN. vinmantoo 04/30/16 02:53:30 PM
#201066   The ORR (original endpoint) has dropped from 35% xavierprivas 04/30/16 09:08:23 AM
#201065   The exit of a key management member of iandy 04/29/16 10:25:26 PM
#201064   Gilead Judge Re-Opens Case Amid Claim Merck Scientist jbog 04/29/16 09:49:37 PM
#201063   Here is the link to the Nuplazid label: biotech jim 04/29/16 08:30:28 PM
#201062   I do agree that IMGN created some confusion skitahoe 04/29/16 07:25:52 PM
#201061   The U.S. Food and Drug Administration today approved WID 04/29/16 06:07:16 PM
#201060   Acad gets approval but box warning ronpopeil 04/29/16 05:56:33 PM
#201059   The exit of a key management member of jellybean 04/29/16 03:51:39 PM
#201058   Igonber- SGYP I haven't a clue. However, when biotech_researcher 04/29/16 01:45:33 PM
#201057   That takeout price is intense. Almost half hazard!! puravida 04/29/16 01:19:46 PM
#201056   can you elaborate? you mean he was fired? thanks lgonber 04/29/16 01:15:23 PM
#201055   Pick 3 Contest #4 Deadline Less then 3 SSKILLZ1 04/29/16 01:05:46 PM
#201054   SGYP- The fact that the CFO's departure was biotech_researcher 04/29/16 01:01:23 PM
#201053   "personal reasons" could be anything. it is an iandy 04/29/16 12:13:31 PM
#201052   "personal reasons" could be anything. it is an lgonber 04/29/16 11:53:29 AM
#201051   ALR acknowledges that ABT tried to walk away DewDiligence 04/29/16 11:31:57 AM
#201050   SGYP - the only explanation provided for the iandy 04/29/16 11:31:41 AM
#201049   BIIB/ABBV—CHMP approves Zinbryta (daclizumab) for relapsing MS: DewDiligence 04/29/16 11:27:57 AM
#201048   CHMP approves GILD’s Odefsey: DewDiligence 04/29/16 11:23:59 AM
#201047   RXDX sells 9.2M* shares @$6.25—a 17% discount to DewDiligence 04/29/16 11:20:40 AM
#201046   TBPH sells 5.48M* shares @$21.00—an 11% discount to DewDiligence 04/29/16 11:17:38 AM
#201045   part of sgen's value is in their ADC dewophile 04/29/16 11:04:42 AM
#201044   IMGN -17% on design change in FORWARD-1 trial: DewDiligence 04/29/16 10:54:51 AM
#201043   OCRX: Ocera Therapeutics Reports First Quarter 2016 Financial ghmm 04/29/16 09:47:07 AM
#201042   MDVN rejects SNY’s buyout offer (again): DewDiligence 04/29/16 09:38:24 AM
#201041   How do those numbers compare to Q4 2015?Please DewDiligence 04/29/16 09:34:48 AM
#201040   ANIK: north40000 04/29/16 09:26:11 AM
#201039   The Full Story Behind Bloomberg's Attempt To "Unmask" hptaxis 04/29/16 07:50:20 AM
#201037   Unmasking the Men Behind Zero Hedge, Wall Street's hptaxis 04/29/16 07:11:22 AM
#201036   SGYP. As you are long the stock, what lgonber 04/29/16 05:50:01 AM
#201035   How do those numbers compare to Q4 2015? tmoney2555 04/29/16 01:32:24 AM
#201034   I am starting to lose my interest in mr_o 04/28/16 10:43:54 PM
#201032   Unless there are some milestones booked, it looks jbog 04/28/16 09:23:29 PM
#201031   One of the deaths made reference to a jellybean 04/28/16 07:41:14 PM
#201030   BIOC -13%/AH on warrant-based financing of undetermined size: DewDiligence 04/28/16 06:34:44 PM
#201029   Calendar 1Q16 V-Pak vs Harvovi (GT1 patients) $ DewDiligence 04/28/16 06:12:34 PM
#201028   Re: HCV in China DewDiligence 04/28/16 05:21:31 PM
#201027   AMGN 1Q16 CC slides: DewDiligence 04/28/16 04:47:15 PM
#201026   GILD 1Q16 CC slides: DewDiligence 04/28/16 04:46:30 PM
#201025   GILD -6%/AH on 1Q16 revenue below consensus: DewDiligence 04/28/16 04:38:08 PM
#201024   BMY—Given that Eliquis [in addition to Opdivo] is DewDiligence 04/28/16 03:48:43 PM
#201023   I don't follow mdvn at all and i linhdtu 04/28/16 03:40:05 PM
#201022   BMY - Opdivo - Growth in sales last Rocky3 04/28/16 03:39:20 PM
#201021   ...had pegged [ABBV] (along w roche) as a DewDiligence 04/28/16 03:29:38 PM
#201018   Have you seen anything from MDVN re what ilpapa 04/28/16 03:17:20 PM
#201017   A Hole in One? Eagle Sues FDA Over hptaxis 04/28/16 01:56:41 PM
#201016   ABBV likes ADCs - i had pegged them dewophile 04/28/16 01:22:25 PM
#201015   Check out ADMP - new SA article out today Jockimo 04/28/16 12:35:07 PM
#201014   It can't be final. right now mr mkt linhdtu 04/28/16 12:01:57 PM
PostSubject